In relation with secondary prevention, we know that aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit production of prostaglandins and cyclooxygenase 2, and they are potential agents for chemoprevention of breast cancer. This evidence concerns the gene PTGS2 and breast carcinoma.